Nasal Immunotherapy Shows Promise in Reducing Inflammation and Boosting Cognitive Function in Alzheimer's Disease

▴ Alzheimer's Disease
The discovery of nasal immunotherapy with anti-CD3 as a potential treatment for Alzheimer's disease represents a ray of hope for the millions of individuals and their families affected by this devastating condition.

Alzheimer's disease is a devastating condition characterized by neurodegeneration and inflammation in the brain. Finding effective treatments for this complex disease has been challenging, as most existing therapies focus on targeting amyloid beta plaques and require early intervention through intravenous therapy. However, recent research has unveiled a promising new approach - nasal immunotherapy with anti-CD3 - which has shown potential in reducing inflammation and enhancing cognitive function in Alzheimer's disease.

The Breakthrough:

In a groundbreaking study published in the journal PNAS, researchers have uncovered preclinical evidence suggesting that nasal immunotherapy can offer significant benefits to individuals battling Alzheimer's disease. What sets this therapy apart is its ability to reduce inflammation and improve cognition independently of amyloid beta plaque levels.

Anti-CD3 Nasal Immunotherapy:

The novel nasal immunotherapy, referred to as anti-CD3, has shown remarkable results in Alzheimer's mouse models. The treatment involves administering anti-CD3 intranasally three times a week for five months. During this time, researchers observed a notable decrease in the activation of microglia, which are immune cells responsible for inflammation in the brain.

Improved Cognitive Function:

The positive effects of anti-CD3 immunotherapy were not limited to reduced inflammation. Treated mice exhibited enhanced cognitive function as demonstrated by improved performance in various behavioral tests, including a water maze. These improvements in cognition are a significant breakthrough, as cognitive decline is a hallmark of Alzheimer's disease.

Immune System Response:

The study also unveiled intriguing changes in gene expression patterns within the brain and an expansion of regulatory T cells, which play a crucial role in fighting diseases in the body. Importantly, all of these changes occurred independently of amyloid beta plaque levels, suggesting that this therapy targets aspects of Alzheimer's disease that have previously been challenging to address.

Promising Implications:

Corresponding author Howard L. Weiner from the Department of Neurology at Brigham and Women's Hospital in the US expressed "We provide evidence that intranasal anti-CD3 therapy can dampen microglia activation and expand T cells in a murine model of Alzheimer’s. This represents a unique approach to treating later-stage Alzheimer’s that can be applied to other inflammatory disease conditions as well."

Future Prospects:

Researchers are now planning to further investigate the potential of anti-CD3 immunotherapy in combination with anti-amyloid therapies in animal studies. This step is crucial in understanding how these treatments can work together to provide a comprehensive approach to Alzheimer's disease treatment. Ultimately, the goal is to advance this promising therapy into human clinical trials.

Building on Success:

This exciting breakthrough builds upon previous research by the same team, who explored the use of foralumab, the only fully human anti-CD3 monoclonal antibody treatment, in patients with COVID-19 and multiple sclerosis (MS). These efforts underscore the versatility of anti-CD3 immunotherapy in addressing a range of inflammatory conditions.


The discovery of nasal immunotherapy with anti-CD3 as a potential treatment for Alzheimer's disease represents a ray of hope for the millions of individuals and their families affected by this devastating condition. As researchers continue to explore this innovative approach, there is optimism that it may offer a unique and effective way to combat Alzheimer's disease, while also holding promise for other inflammatory diseases. Further studies and clinical trials will shed more light on the full potential of this therapy in the fight against Alzheimer's

Tags : #alzheimer #nasal #immunotherapy #brainhealth #inflammatorydiseases #anti-CD3 #COVID19 #medicircle

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Will India’s Healthcare Budget Support a Future of Robotic Surgeries?February 22, 2025
Is the World on the Brink of Another Pandemic? Scientists Discover a New Bat VirusFebruary 22, 2025
Newcastle University Expands Academic and Research Collaborations in IndiaFebruary 21, 2025
Get Ready to #BibaUp! Kriti Sanon Unveils the Season’s Most Stylish Summer CollectionFebruary 21, 2025
A Rare Condition: Surgery Saves 2-Day-Old Baby as Organs Shift Into ChestFebruary 21, 2025
Odisha’s Bold Healthcare Vision: A Rs 12,000 Crore Blueprint for Universal Health AccessFebruary 21, 2025
Young India’s Health Crisis: Why Insurance Claims Are Rising Among 25-35 Year OldsFebruary 21, 2025
India vs. Trump’s Pharma Tariff: The Battle Over Affordable MedicineFebruary 21, 2025
Foreign Medical Aspirants in Trouble: NMC’s Warning on Pending Eligibility CertificatesFebruary 21, 2025
Think Your Work Music Helps You Focus? Science Says Think AgainFebruary 21, 2025
Is Your Home’s Air Poisoning You? Shocking New Study Reveals Hidden Indoor Pollution RisksFebruary 20, 2025
The Society of Automotive Engineers & B V Raju Institution of Technology; to host the globally prestigious E-BAJA 2025; at Hyderabad!February 20, 2025
Eat right for your heart to beat rightFebruary 19, 2025
Aakash Healthcare and Medtronic Inaugurate North India’s First Dedicated Vein ClinicFebruary 19, 2025
Urgent and accelerated HIV service delivery with equity and rights is critical to end AIDSFebruary 19, 2025
Fasting Fad or Future Health Threat? Why Teens Should Think Twice Before Intermittent Fasting February 19, 2025
Public Hospitals Go High-Tech: AIIMS Delhi Leads India’s Robotic Surgery WaveFebruary 19, 2025
Screen Time and Healthy Habits: Navigating Optimal Development in ChildrenFebruary 18, 2025
SRM Global Hospitals Launches WOW, a Centre Exclusively for Women’s Health and WellnessFebruary 18, 2025
The Hidden Dangers of Scented Candles: Aesthetic Bliss or Silent Health Hazard?February 18, 2025